1.10
+0.01(+0.92%)
Currency In USD
| Previous Close | 1.09 |
| Open | 1.1 |
| Day High | 1.13 |
| Day Low | 1.08 |
| 52-Week High | 6.07 |
| 52-Week Low | 1.06 |
| Volume | 93,047 |
| Average Volume | 231,054 |
| Market Cap | 3.61M |
| PE | -0.09 |
| EPS | -12.77 |
| Moving Average 50 Days | 1.49 |
| Moving Average 200 Days | 2.55 |
| Change | 0.01 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $17.89 as of February 14, 2026 at a share price of $1.1. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $0.12 as of February 14, 2026 at a share price of $1.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
GlobeNewswire Inc.
Feb 09, 2026 2:05 PM GMT
SAN DIEGO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform fo
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
GlobeNewswire Inc.
Feb 04, 2026 1:00 PM GMT
SAN DIEGO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to detect
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a